sergolexole

structure given in first source

Also Known As:

6-methyl-1-(1-methylethyl)ergoline-8-carboxylic acid, 4-methoxycyclohexyl ester; LY 281067; LY281067; Ergoline-8-carboxylic acid, 6-methyl-1-(1-methylethyl)-, 4-methoxycyclohexyl ester, (8beta(trans))-, (Z)-2-butenedioate (1:1)

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Alkaloids: 5398
  - Ergot Alkaloids: 208
    - Ergolines: 109
      - Lysergic Acid: 42
        sergolexole: 1
- Fused-Ring Heterocyclic Compounds
  - 4 or More Rings Heterocyclic Compounds
    - Ergolines: 109
      - Lysergic Acid: 42
        sergolexole: 1

Related Diseases

1.	Atherosclerosis 05/01/1991 - "To investigate the mechanism of angioplasty-induced vasospasm, the effect of serotonin-receptor blockade with two serotonin2 (S2) antagonists, LY53857 and sergolexole, was examined in rabbits with focal femoral artery atherosclerosis. "

Related Drugs and Biologics

1.	Serotonin Receptors